73.73
-2.05%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About iRay Group
Its shares trade on Shanghai under the ticker 688301.SS. It has been listed since 18 September 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.30bn and net income of CN¥661.3m. At that date it held total assets of CN¥12.82bn and shareholders' equity of CN¥6.07bn.
iRay Technology Co., Ltd. engages in the research, development, production, and sale of digital X-ray detectors. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-18. The firm's products include universal radio frequency series, universal radio frequency series, breast series and radiotherapy series. The firm's products are applied in medical diagnosis and treatment, industrial non-destructive testing and security inspection fields. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 18 Sept 2020
- Employees
- 1,237
- Website
- iraygroup.com ↗
Leadership
Pay as last reported
- Mr. Tie GuChairman of the Board, General Manager, since 2014CN¥1.5m
- Mr. Kai ZhaoChief Financial OfficerCN¥694,700
- Mr. Zhiqiang FangSenior Vice President-R&D Center, Deputy General Manager, since 2020CN¥1.0m
- Mr. Yimin HuangSenior Vice President - R&D Center, Deputy General Manager
- Mr. Richard AufrichtigSenior Vice President - Sales, Director, since 2022
- Mr. Chengbin QiuChief Technology Officer, Deputy General Manager, Director, since 2011CN¥1.3m
- Mr. Xiaoyu DongDeputy General ManagerCN¥323,600
- Mr. Guohua ZhangDeputy General ManagerCN¥583,200
- Mr. Dong ZhaoDeputy General ManagerCN¥44,600
- Ms. Min QiuSecretary of the Board, since 2023CN¥665,000
- Mr. Hongguang CaoDirector, since 2012CN¥843,800
- Mr. Weizhen YangDirector, since 2011CN¥843,800
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 74
- Environment
- 99
- Social
- 84
- Governance
- 40
- Direct emissions (scope 1)
- 886.3 t
- Energy emissions (scope 2)
- 21,239.5 t
- Women in the workforce
- 28.70325%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Headquartered in Shanghai with 1,237 employees
- IPO on 2020-09-18 provides market access
- Products include digital X-ray detectors for medical and industrial use
Weaknesses
- Products listed as universal radio frequency series twice in description
- No specific market share or revenue figures provided
- Source description is untrusted and contains redundant product listings
Opportunities
- Expansion into overseas markets for product distribution
- Growth potential in medical diagnosis and treatment applications
- Diversification into industrial non-destructive testing and security inspection
Threats
- Untrusted source description may lead to inaccurate data
- Redundant product listings could confuse potential customers
- Lack of detailed financial information may hinder investor confidence
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.